PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Cancer Research and Treatment10.4143/crt.2014.1832016481153-161The Role of Plasma Chromogranin A as Assessment of Treatment Response in Non-functioning Gastroenteropancreatic Neuroendocrine TumorsMoonjin Kim, Sujin Lee, Jeeyun Lee, Se Hoon Park, Joon Oh Park, Young Suk Park, Won Ki Kang, Seung Tae Kimhttp://e-crt.org/upload/pdf/crt-2014-183.pdf, http://e-crt.org/journal/view.php?doi=10.4143/crt.2014.183, http://www.e-crt.org/upload/pdf/crt-2014-183.pdf
HPB10.1016/j.hpb.2021.08.349202123S837-S838Role of chromogranin A-derived fragments in the assessment of surgical efficacy after resection of non-functioning pancreatic neuroendocrine tumorsV. Andreasi, S. Partelli, M. Manzoni, B. Colombo, F. Muffatti, A. Corti, M. Falconihttps://api.elsevier.com/content/article/PII:S1365182X21009898?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1365182X21009898?httpAccept=text/plain
Surgery10.1016/j.surg.2018.12.00420191665952Chromogranin A usefulness in small non-functioning pancreatic neuroendocrine tumors surgical managementGiuseppe Lamberti, Nicole Brighi, Davide Campanahttps://api.elsevier.com/content/article/PII:S0039606018308286?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0039606018308286?httpAccept=text/plain
Gastroenterology10.1016/s0016-5085(00)84725-320001184A647High sensitivity of chromogranin a (CgA) as serum marker of functioning and non-functioning digestive neuroendocrine tumorsCarola Severi, Stefano Angeletti, Renato Cannizzaro, Vito D. Corleto, Paola Pradella, Alessandra Moretti, Angela Buonadonna, Francesco Panzutohttps://api.elsevier.com/content/article/PII:S0016508500847253?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0016508500847253?httpAccept=text/plain
Clinical and Experimental Gastroenterology10.2147/ceg.s5928201079Advances in the treatment of gastroenteropancreatic neuroendocrine tumorsGeorge Fisher, Kunzhttps://www.dovepress.com/getfile.php?fileID=6643
Frontiers in Oncology10.3389/fonc.2021.741096202111The Prognostic and Predictive Role of Chromogranin A in Gastroenteropancreatic Neuroendocrine Tumors – A Single-Center ExperienceHui-Jen Tsai, Chin-Fu Hsiao, Jeffrey S. Chang, Li-Tzong Chen, Ying-Jui Chao, Chia-Ju Yen, Yan-Shen Shanhttps://www.frontiersin.org/articles/10.3389/fonc.2021.741096/full
Annales d'Endocrinologie10.1016/j.ando.2019.04.0092019803175-181Gastroenteropancreatic neuroendocrine tumors: Role of surgeryAlain Sauvanethttps://api.elsevier.com/content/article/PII:S0003426619300617?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0003426619300617?httpAccept=text/plain
Frontiers of Hormone Research10.1159/0004037852015239-247The Role of Chemotherapy in Well-Differentiated Gastroenteropancreatic Neuroendocrine TumorsJonathan Strosberg, Jamie Goldman, Frederico Costa, Marianne Pavelhttps://www.karger.com/Article/Pdf/403785, https://www.karger.com/Article/Pdf/403785
Gastroenterology10.1016/0016-5085(95)26173-719951084A465High-dose lanreotide treatment in patients with metastatic neuroendocrine gastroenteropancreatic tumorshttps://api.elsevier.com/content/article/PII:0016508595261737?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:0016508595261737?httpAccept=text/plain
Cancers10.3390/cancers4010113201241113-129Medical Treatment of Gastroenteropancreatic Neuroendocrine TumorsAnja Rinke, Patrick Michl, Thomas Gresshttp://www.mdpi.com/2072-6694/4/1/113/pdf